Results 51 to 60 of about 1,463 (147)

Micropulse cyclophotocoagulation in the treatment of primary open-angle glaucoma and congenital glaucoma. Part 1: hypotensive effect mechanisms, modern procedure protocol

open access: yesРоссийский офтальмологический журнал
Micropulse cyclophotocoagulation (MP-CPC) refers to interventions that reduce intraocular pressure by laser exposure on the ciliary body, while the term “coagulation” in its name does not reflect the essence of the procedure, but is inherited from the ...
O. V. Ermakova, E. A. Ragozina
doaj   +1 more source

Evidence-Based Consensus Guidelines Series for MicroPulse Transscleral Laser Therapy: Dosimetry and Patient Selection

open access: yesClinical Ophthalmology, 2022
Tomas M Grippo,1 Ronald MPC de Crom,2 Michael Giovingo,3 Marc Töteberg-Harms,4 Brian A Francis,5 Brian Jerkins,6 Jacob W Brubaker,7 Nathan Radcliffe,8 Jella An,9 Robert Noecker10 1Department of Ophthalmology, Hospital Aleman, Buenos Aires, Argentina ...
Grippo TM   +9 more
doaj  

Effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema

open access: yesJournal of Current Ophthalmology, 2019
Purpose: To evaluate the effects of subthreshold diode micropulse laser photocoagulation on treating patients with refractory diabetic macular edema (DME).
Mohammadreza Akhlaghi   +4 more
doaj   +1 more source

Subthreshold micropulse yellow 577 nm laser therapy of diabetic macular oedema in rural and urban patients of south-eastern Poland

open access: yesAnnals of Agricultural and Environmental Medicine, 2017
Objectiv To evaluate the efficacy of subthreshold micropulse yellow (577 nm) laser photocoagulation in diffuse macular edema (DME) in rural and urban patients of south-eastern Poland.
Małgorzata Latalska   +3 more
doaj   +1 more source

Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

open access: yesBMC Ophthalmology, 2020
Background To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizumab alone.
Olga Furashova   +3 more
doaj   +1 more source

Our first experience with subtreshold diode laser in the treatment of macular edema

open access: yesZdravniški Vestnik, 2012
Authors describe their first experience with the treatment of macular edema of different etiology with subtreshold diode micropulse laser (577 nm), which does not cause any damage to the retinal pigment epithelium.
Davorin Sevšek   +2 more
doaj  

Micropulse laser therapy in chronic idiopathic central serous chorioretinopathy in right eye of 38-year-old patient – case report

open access: yesAnnales Academiae Medicae Silesiensis
INTRODUCTION: Central serous chorioretinopathy (CSC) is a disease characterized by idiopathic serous elevation of the sensory layer of the retina in the proximity of the macula.
Maciej Michalik   +3 more
doaj   +1 more source

Micropulse P3™ (MP3) Laser for Glaucoma: An Innovative Therapy

open access: yesJournal of Current Glaucoma Practice, 2018
How to cite this article: Aquino MC, Lim D, Chew PTK. Micropulse P3™(MP3) Laser for Glaucoma: An Innovative Therapy. J Curr Glaucoma Pract 2018;12(2):51-52.
Aquino, Maria Cecilia   +2 more
openaire   +2 more sources

Diabetic macular oedema and diode subthreshold micropulse laser (DIAMONDS): study protocol for a randomised controlled trial

open access: yesTrials, 2019
Background In the UK, macular laser is the treatment of choice for people with diabetic macular oedema with central retinal subfield thickness (CST)
Noemi Lois   +27 more
doaj   +1 more source

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy

open access: yesClinical Ophthalmology, 2015
Ahmed Hosni Abd ElhamidDepartment of Ophthalmology, Ain Shams University, Cairo, EgyptPurpose: To report the efficacy and safety of micropulse 577 nm yellow laser in the treatment of nonresolving central serous chorioretinopathy (CSC) cases.Patients
Abd Elhamid AH
doaj  

Home - About - Disclaimer - Privacy